Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Huirui Wang
Observed name:
H H Wang
Institution:
Luoyang Central Hospital Affiliated to Zhengzhou University
Observed institutions:
Henan University of Science and Technology,
Luoyang Central Hospital Affiliated to Zhengzhou University
ORCID:
0000-0003-3577-5861
Observed ORCID:
0000-0003-3577-5861
OpenAlex ID:
A5000967520
A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states
2022
·
Ruihua Mi
, Lin Chen
, et al.
·
Annals of Translational Medicine
·
4
PDF
[High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma].
2019
·
J L Gu
, J Li
, et al.
·
PubMed Central
·
4
PDF
[Bortezomib-based induction chemotherapy followed by autologous hematopoietic stem cell transplantation and maintenance in 200 patients with multiple myeloma: long-term follow-up results from single center].
2019
·
Q Wu
, J R Liu
, et al.
·
PubMed Central
·
4
PDF
A Case Report of IgA‐κ Type Multiple Myeloma Complicated With Hyperlipidemia
2025
·
Jie Li
, Jiashan Zhao
, et al.
·
Clinical Case Reports
·
3
DNA Hypermethylation of the ZNF382 Promoter Region and Low mRNA Expression of ZNF382 Promote Diffuse Large B‐Cell Lymphoma Occurrence and Progression
2026
·
Wanhua An
, Shuli Guo
, et al.
·
Cancer Reports
PDF
Combined Thalidomide and Recombinant Human Interferon-α-1b and Interleukin-2 for Acute Myeloid Leukemia of Various Disease Status: A Multi-Center Prospective Study
2021
·
Ruihua Mi
, Lin Chen
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
6
Citation count:
15
H-index:
3
I10-index:
Year
Topic
Type